MSPAF yields 33.78% · PFE yields 6.13%● Live data
📍 MSPAF pulled ahead of the other in Year 1
Combined, MSPAF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MSPAF + PFE for your $10,000?
Growens S.p.A., together with its subsidiaries, engages in the cloud marketing technology business in Italy, other European countries, the Americas, and Asia. It operates through E-mail Marketing, Mobile Marketing/Messaging, and Marketing Automation Segments. The company is involved in the development and sale of technologies for the mass sending of e-mails and mobile messaging through the SMS channel for marketing and transaction purposes. It also provides e-mail and newsletter editing tools; marketing technology solutions; and professional consulting services. In addition, the company offers MailUp, a platform that offers data presentation tools, including statistics for engagement that presents statistical data to help users enhance the effectiveness of their campaigns through e-mail and then to take corrective actions to enhance the performance of future campaigns, as well as the multi-list dashboard feature, which is a summary tool to have an immediate overview of the progress of campaigns. Further, it provides BEE, a drag-and-drop editor for e-mails and landing pages; Acumbamail, a Spanish e-mail marketing platform, which allows the creation, sending, and management of multi-channel marketing campaign; and Datatrics platform, which allows the marketing teams to build experiences based on data managed by artificial intelligence. The company was formerly known as Mailup S.p.A. and changed its name to Growens S.p.A. in April 2021. Growens S.p.A. was founded in 2002 and is headquartered in Milan, Italy.
Full MSPAF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.